Claris from India is a pharmaceutical company that specializes in the development, manufacturing, and marketing of sterile injectable products. It was established in 1999 with the aim of catering to the growing demand for injectable products in the Indian market. Headquartered in Ahmedabad, Gujarat, Claris has state-of-the-art manufacturing facilities that comply with international quality standards.

The company's headquarters serve as a hub for its operations, research and development, quality control, and regulatory affairs. The company's main products include generic injectable drugs, anesthesia products, and critical care medications. Additionally, Claris offers contract manufacturing services to various pharmaceutical companies worldwide.

It has a strong global presence with a distribution network spanning over 100 countries. Claris has formed several noteworthy partnerships and acquisitions to enhance its operational capabilities and expand its product portfolio. In 2011, the company entered into a partnership with Baxter International, a leading global healthcare company.

This collaboration allowed Claris to leverage Baxter's expertise in injectable drug delivery systems. In terms of market position, Claris is a prominent player in the global pharmaceutical industry. The company has achieved significant sales growth, primarily driven by its strong presence in emerging markets like India, Brazil, South Africa, and several countries in Southeast Asia.

Claris competes with other major pharmaceutical companies in the sterile injectables market, including Pfizer, Hospira, and Mylan. Over the years, Claris has achieved numerous milestones and accolades. It has received various international certifications for its manufacturing facilities, including the US Food and Drug Administration (FDA) approval.

These certifications validate the company's commitment to maintaining the highest standards of quality and safety in its products. As of the latest information available, Claris has recently undergone a significant transformation. In 2017, Baxter International acquired Claris, merging it with its own injectables business to form Baxter India.

This acquisition has created an even stronger presence for Claris and expanded its reach in the global pharmaceutical market. In conclusion, Claris from India is a leading pharmaceutical company specializing in sterile injectable products. With its strong global presence, extensive product portfolio, and strategic partnerships, the company continues to make significant contributions to the healthcare industry